[Research Report] Results of Survey on the Japanese Government’s Response to COVID-19 (December 14, 2021)
date : 12/14/2021
Tags: Global Health, Survey on Healthcare in Japan, Vaccinations
Health and Global Policy Institute (HGPI) conducted a nationwide online survey (1,000 respondents; 494 male, 506 female; ages 18 to 79) regarding the Japanese government’s international support, including vaccines, in the context of global health.
In order to end the fight against the pandemic, recent discussions on COVID-19 vaccine policies need to consider human health on a global scale and respond to COVID-19 in developing countries through international cooperation. Furthermore, the Special Session on WHA, hosted by the World Health Organization (WHO), also reaffirmed the importance of equitable distribution of vaccines in the context of global health. According to the Global Dashboard for Vaccine Equity by the United Nations Development Programme (UNDP), one in two people in high-income countries are vaccinated, while only one in 18 people are vaccinated in low-income countries. This will not only affect the economy, society, and health of unvaccinated people in low-income countries but also have a significant impact on the world, such as the possible emergence of new mutant viruses and on the economic and social activities connected by global value chains.
This survey examined how Japan should approach international vaccine-related issues as an advanced country, and the public awareness of vaccine policies. The summary of the survey results is as follows.
1. Equitable distribution of vaccines
When asked about their thoughts on the lack of progress in vaccinations in certain places, such as Africa, the majority of the respondents (54.5%) stated, “from the perspective of the global economy, the vaccines should be distributed around the world,” while others (34.8%) stated, “it is unfair that there is a difference in vaccine distribution depending on the country.”
2. Japanese government’s measures to donate vaccines to other countries
When asked about their thoughts on the free provision of vaccines by the Japanese government to countries and regions in need of the COVID-19 vaccines, almost 90% (86.6%) expressed their support for the matter.
3. Japan’s role in addressing international issues.
When asked about their thoughts on Japan’s role in addressing international issues, about half of the respondents (46.5%) expected the Japanese government to play a “major role.”
4. Priorities of the Japanese government’s response to COVID-19 for other countries
When asked whether financial assistance or the donation of vaccine doses is more important for the Japanese government’s support to other countries, the number of respondents for financial assistance (14.5%) was significantly outnumbered by those for the donation of vaccine doses (57.0%).
5. Public awareness of the term “global health”
When asked whether they knew and understood the term “global health”, the majority of the respondents (83.0%) did not know the term or its definition.
The Japanese government has announced that they will establish a “Global Health Strategy” at the Health and Medical Strategy Promotion Council by June 2022. It is important to proceed by incorporating the lessons learned from the responses to this pandemic while considering the achievement of the Sustainable Development Goals (SDGs) and obtaining the citizens’ understanding.
*The full report of the research written in English will be available on this website in due course.
Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Recommendations on Strategic Investments in Policies for Brain Health to Revitalize Japan: Hopes for the New Administration (December 1, 2025)
- [Announcement] HGPI Endorses the “Belém Health Action Plan” (November 14, 2025)
- [Announcement] HGPI Joins Global Green and Healthy Hospitals (August 1, 2023)
- [Research Report] AMR Policy Update #2: WHO’s First Report on Fungal Infection—Bridging the Gap Between Clinical Practice and R&D
Featured Posts
-
2025-12-09
[Event Report] Special Seminar “Rising to New Challenges in Health Sciences for Future Society: Novel Developments in the Field of Epilepsy in Japan and Globally” Belgium Pavilion Special Seminar, World Expo 2025 Osaka, Kansai (September 18, 2025)
-
2025-12-11
[Event Report] Core Components of Universal Health Coverage (UHC): Achieving “Healthcare Without Financial Hardship” in Asia-Pacific and Japan (December 5, 2025)
-
2025-12-12
[Registration Open] Meaningful Involvement Promotion Project Urgent Symposium “The New Takaichi Administration and Central Social Insurance Medical Council Reform – Ensuring Patients’ Voices are Heard” (January 22, 2026)
-
2025-12-12
[Registration Open] (Webinar) The 140th HGPI Seminar “Early Detection to Reduce COPD Disease Burden: Connecting Clinical Frontiers with Health Policy” (January 27, 2026)
-
2025-12-16
[Discussion Points] Policy Dialogue “Considering Comprehensive Genomic Profiling from the Perspective of Patient Access: Utilizing the Medical Service Fee Reimbursement System and the Mixed Medical Services Program to Meet the Needs of Today” (November 28, 2025)



